The Department of Liver Surgery of West China Hospital, Sichuan University, is a National Key Discipline, a key clinical specialty of the National Health Commission, a constructive discipline of the 211 Project as well as the Training Center of General Surgery Specialist certified by the Royal College of Surgeons of Edinburgh and the College of Surgeons of Hong Kong. It also serves as the Liver Cancer Center of Western China and the West China Liver Transplantation Center of Sichuan University. There are currently 31 doctors, including 8 doctoral tutors. The Department now has 92 beds at the main campus and 30 beds at Shangjin Hospital (a branch campus). The Department is especially well-known for its capability of treating difficult and complicated hepatobiliary diseases, and some leading technics domestically and internationally in the fields such as surgery and interventional treatment for liver cancer, minimally invasive liver resection, DCD liver transplantation, living donor liver transplantation, exo-hepatectomy and auto-liver transplantation for hydatid disease.

The Department has 31 doctors, including 10 professors, 8 associate professors, 10 attending doctors and 4 residents, 30 of whom have Ph.D degree. In the list of staff, there are 8 doctoral tutors and 11 master tutors. The Department has successively dispatched its doctors to famous universities in USA, Canada, Europe and Japan for further study or research. There are 33 nurses, with 1 having senior title, 10 nurse-in-charge and 22nurses. In terms of educational background, there are 1 postgraduate, 23 undergraduates and 8 junior college students. 

Surgical and Interventional Treatment for Liver Cancer: The department carries out about 1,500 hepatectomy every year, of which about 1,200 cases for liver cancer recurrence of liver cancer and re-recurrent liver cancer, minimally invasive liver resection (laparoscopic and robotic assisted) reaches 30%. ALPPS surgery is routinely performed. The Department has an intervention and minimally invasive treatment group, which routinely carries out hepatic arterial chemoembolization with liver iodized oil, drug-loaded microsphere chemoembolization and radiofrequency ablation. It works closely with the surgical team to induce the second stage resection by portal vein embolism (PVE). The Department is also the first one in China to carry out hepatic venous deprivation (LVD) to induce two-stage liver resection.

DCD Liver transplantation and live donor living transplantation: The Department performed the first case of clinical liver transplantation surgery in western China at the end of the 1970s. In the past 2 decades, the Liver Transplant Center of West China Hospital, Sichuan University, performed nearly 1,700 cases of liver transplantation under the leadership of Professor Yan Lvnan, a famous liver surgery expert. Among these cases, there are nearly 600 cases of living donor liver transplantation, with the surgical success rate of 100% and the 1-year, 3-year and 5-year survival rates for benign liver diseases up to 87.4%, 85.2% and 80.5% respectively, at a leading level both at home and abroad. The adult-to-adult living donor liver transplantation (A-ALDLT) in this department is always ranked first in the mainland China.